India to Grenada Pharmaceutical Export (2026) — $685.4K, 37 Suppliers | TransData Nexus

India to Grenada Pharmaceutical Export (2026) — $685.4K, 37 Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — India to Grenada

#	Formulation	Value	Share
1	Tenofovir Disoproxil Fumarate 300mg + Efavirenz 600mg + Emtricitabine 200mg Tab…	$56.3K	8.2%
2	(pharmaceutical Product Finished Formula	$32.9K	4.8%
3	Pharmaceutical Product Finished Formulation Ibrutinib Capsules 140mg	$28.5K	4.2%
4	Meningococcal 16mcg & Diphtheria Toxoid 48mcg -menactra	$11.7K	1.7%
5	Contain Medicines Harmless Pharmaceutic	$10.1K	1.5%
6	Mega Cv 600mg Injction (amoxycilin 500mg+potassium Clavunate 100mg) - 1 X 1vial	$9.8K	1.4%
7	Medicines for Consumption and the Descri	$8.2K	1.2%
8	Infliximab 100 MG - Vial - (infimab)	$7.1K	1.0%
9	Pharmaceutical Product Finished Formulation Goserelin Acetate Implant Injection…	$6.5K	1.0%
10	Pharmaceutical Product Finished Formulation Human Normal Immunoglobulin 5gm - 1…	$6.4K	0.9%
11	Trastuzumab 440 MG for Injection - Vial -(canmab)vls	$5.8K	0.8%
12	Albu High 20%	$5.7K	0.8%
13	Pertuzumab Injection 420mg /14 ML - Vial	$5.3K	0.8%
14	Voveran Sr 75mg Diclofenac (75mg) Pack Size 10 Tablets Batch No.202swbc4	$5.1K	0.7%
15	Pharmaceutical Product Finished Formulation Cyproheptadine Hydrochloride Tablet…	$4.8K	0.7%

India exports 20+ pharmaceutical formulations to Grenada with a combined trade value of $685.4K. Key products include Tenofovir ($56K). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 2,804 verified Indian Customs (DGFT) shipment records.

Top Pharmaceutical Products — India to Grenada Trade Routes

1Tenofovir$56K

These are the top pharmaceutical products exported from India to Grenada, each with a dedicated trade route analysis page. Click any product to see detailed export data including Indian suppliers, Grenada buyers, regulatory requirements, and logistics for that specific product corridor. Products include Tenofovir ($56K) — all finished pharmaceutical formulations verified from Indian Customs (DGFT) records.

Top Indian Exporters to Grenada

1Medigen Pharma

$278K

2Mylan Laboratories Limited

$61K

3Vea Impex (i) Private Limited

$57K

4Brinton Pharmaceuticals Limited

$48K

5Sunny Pharma

Port Analysis — India to Grenada Pharmaceutical Shipments

Indian Export Ports

SAHAR AIR CARGO ACC (INBOM4)41.2%

SAHAR AIR25.4%

LCS JAIGAON0.6%

Bombay Air Cargo5.8%

LCS JAIGAON (INJIGB)2.4%

Grenada Import Ports

GRENADA88.4%

Saint George's0.4%

ST GEORGE0.5%

GEORGR TOWN1.0%

Trade Statistics

Total Value$685K

Shipments2,804

Indian Exporters37

Grenada Buyers45

Avg Shipment$244

Products2,133

Other Destinations

United States$8.8B United Kingdom$1.2B Canada$1.1B France

Last updated: March 28, 2026

India–Grenada Pharmaceutical Trade Corridor Analysis

Historical evolution, India's market position, and recent developments

1Trade Corridor Evolution

The pharmaceutical trade between India and Grenada has experienced steady growth over recent years. In 2024, Grenada imported pharmaceutical products valued at approximately $549,910 from India, marking a significant increase from previous years. This upward trajectory underscores the strengthening trade relations and the growing reliance of Grenada on India's pharmaceutical exports.

Key milestones in this bilateral trade include the establishment of direct shipping routes and the initiation of collaborative efforts to streamline regulatory processes. These developments have facilitated smoother transactions and enhanced the efficiency of the supply chain, benefiting both nations. The consistent growth in trade volume reflects the successful implementation of these initiatives and the mutual commitment to expanding the pharmaceutical trade corridor.

2India's Market Position

India holds a dominant position in Grenada's pharmaceutical import landscape. In 2024, pharmaceutical products from India accounted for a substantial portion of Grenada's total imports, highlighting India's strategic importance as a supplier. This dominance is attributed to India's competitive pricing, adherence to international quality standards, and the extensive range of pharmaceutical products it offers.

The strong market presence of Indian pharmaceutical companies in Grenada is further evidenced by the active participation of multiple Indian exporters in the Grenadian market. This widespread engagement not only reinforces India's market share but also fosters deeper economic ties between the two nations.

Grenada Regulatory Landscape for Indian Pharmaceutical Exports

Registration process, GMP requirements, import documentation

1Registration Process

Indian pharmaceutical companies seeking to register products in Grenada must adhere to the guidelines set forth by the National Drug Regulatory Authority, which operates under the World Health Organization's Good Manufacturing Practices (WHO-GMP) standards. The registration process involves submitting a comprehensive dossier that includes the Common Technical Document (CTD) format, which is internationally recognized for its structured approach to regulatory submissions.

The dossier should encompass detailed information on the product's composition, manufacturing process, quality control measures, and clinical data demonstrating safety and efficacy. Bioequivalence studies are typically required to establish therapeutic equivalence with the reference product. The review timeline for product registration can vary, but applicants should anticipate a thorough evaluation process that may extend several months.

2GMP & Facility Requirements

Grenada mandates that all pharmaceutical products imported into the country comply with WHO-GMP standards. Indian manufacturing facilities must undergo inspections to verify adherence to these standards, ensuring that products are consistently produced and controlled to meet quality requirements. The inspection process is rigorous, focusing on aspects such as facility design, equipment calibration, personnel qualifications, and documentation practices.

Mutual recognition agreements between Grenada and India may facilitate the acceptance of GMP certifications issued by recognized authorities in India. However, it is imperative for Indian manufacturers to stay updated on any changes in Grenadian regulatory policies and to maintain compliance with both national and international GMP standards to ensure uninterrupted market access.

3Import Documentation

To import pharmaceutical products into Grenada, Indian exporters must provide specific documentation to comply with Grenadian regulations. This includes a Certificate of Pharmaceutical Product (CPP), which attests to the product's quality and compliance with GMP standards, and a Certificate of Analysis (CoA), detailing the product's composition and quality attributes.

Customs procedures for pharmaceutical imports into Grenada require that all shipments be accompanied by these certificates, along with a valid import license issued by the Grenadian authorities. Importers must ensure that all documentation is accurate and complete to facilitate smooth customs clearance and to prevent potential delays or rejections at the port of entry.

TransData Nexus Research · Grenada regulatory databasesMar 2026

Product Categories & Therapeutic Trends — India to Grenada

Dominant categories, emerging opportunities, and demand drivers

1Dominant Categories

The pharmaceutical exports from India to Grenada are predominantly composed of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. This trend aligns with Grenada's healthcare needs, as the country relies heavily on imported medicines to meet the demands of its population. The absence of large-scale pharmaceutical manufacturing within Grenada necessitates the importation of these ready-to-use products to ensure timely and effective healthcare delivery.

Therapeutic areas such as antiretrovirals, oncology, and vaccines are particularly significant in this trade corridor. The prevalence of diseases requiring these treatments in Grenada drives the demand for such pharmaceutical products, making them key categories in the bilateral trade.

2Emerging Opportunities

The expiration of patents for several blockbuster drugs presents opportunities for Indian pharmaceutical companies to introduce generic versions into the Grenadian market. Additionally, the increasing demand for biosimilars offers a promising avenue for Indian exporters to expand their product offerings. By leveraging their expertise in these areas, Indian companies can meet the evolving healthcare needs of Grenada's population.

Furthermore, the expansion of Grenada's healthcare infrastructure and the government's focus on improving healthcare access create a conducive environment for Indian pharmaceutical companies to introduce new therapeutic areas and innovative products. This strategic alignment can lead to mutually beneficial growth in the pharmaceutical trade between the two nations.

3Demand Drivers

Grenada's disease burden, characterized by a high prevalence of chronic conditions such as hypertension, diabetes, and infectious diseases, significantly drives the demand for pharmaceutical imports. The aging population further exacerbates the need for a diverse range of medical treatments, increasing the reliance on imported pharmaceutical products.

Healthcare spending trends in Grenada indicate a growing investment in medical services and infrastructure, reflecting a commitment to improving health outcomes. This upward trend in healthcare expenditure enhances the purchasing power for pharmaceutical products, thereby boosting import demand from countries like India.

TransData Nexus Research · DGFT trade data analysisMar 2026

Trade Policy & Tariff Intelligence — India and Grenada

Tariff structure, trade agreements, IP and patent landscape

1Tariff & Duty Structure

Grenada's Most Favored Nation (MFN) tariff rates for pharmaceutical formulations are structured to encourage the importation of essential medicines while ensuring affordability. Preferential rates may be applied to imports from countries with which Grenada has established trade agreements, potentially reducing the overall cost of pharmaceutical imports.

Duty exemptions are often granted for pharmaceutical products that are deemed critical for public health. Importers should consult the latest Grenadian customs regulations to determine applicable tariff rates and to identify any exemptions that may apply to their specific product categories.

2Trade Agreements

Grenada is a member of the Caribbean Community (CARICOM), which facilitates trade among member states. While there is no specific Free Trade Agreement (FTA) between India and Grenada, the broader CARICOM-India cooperation framework may offer avenues for enhancing bilateral trade relations. Ongoing negotiations and dialogues aim to explore potential agreements that could further streamline trade procedures and reduce barriers for pharmaceutical exports.

The impact of these agreements on pharmaceutical trade is contingent upon the successful negotiation and implementation of terms that address regulatory harmonization, tariff reductions, and other trade facilitation measures.

3IP & Patent Landscape

Grenada's patent provisions align with international standards, providing protection for pharmaceutical innovations. Data exclusivity periods are in place to safeguard the interests of originators, potentially affecting the entry of generic products into the market. Compulsory licensing provisions exist but are typically invoked under specific circumstances, such as public health emergencies.

For Indian generic manufacturers, understanding Grenada's intellectual property landscape is crucial to navigate patent challenges and to strategize market entry effectively. Engaging with local legal experts and staying informed about regulatory changes can aid in mitigating risks associated with intellectual property rights.

TransData Nexus Research · Trade policy databasesMar 2026

FAQ — India to Grenada Pharmaceutical Trade

What is the total value of India's pharmaceutical export to Grenada?

India exported pharmaceuticals worth $685.4K to Grenada across 2,804 verified shipments.

Who are the top Indian pharmaceutical exporters to Grenada?

1. MEDIGEN PHARMA — $278.3K. 2. MYLAN LABORATORIES LIMITED — $61.0K. 3. VEA IMPEX (I) PRIVATE LIMITED — $56.7K. Total: 37 suppliers.

Which companies in Grenada import pharmaceuticals from India?

1. INVOICE TO — $142.9K. 2. INVOICE RAISED TO — $135.5K. 3. MINISTRY OF HEALTH, — $56.3K. 45 buyers total.

What pharmaceutical products does India export most to Grenada?

1. Tenofovir Disoproxil Fumarate 300mg + Efavirenz 600mg + Emtricitabine 200mg Tab… ($56.3K, 8.2%); 2. (pharmaceutical Product Finished Formula ($32.9K, 4.8%); 3. Pharmaceutical Product Finished Formulation Ibrutinib Capsules 140mg ($28.5K, 4.2%); 4. Meningococcal 16mcg & Diphtheria Toxoid 48mcg -menactra ($11.7K, 1.7%); 5. Contain Medicines Harmless Pharmaceutic ($10.1K, 1.5%)

Which ports handle pharmaceutical shipments from India to Grenada?

Export: SAHAR AIR CARGO ACC (INBOM4), SAHAR AIR, LCS JAIGAON, Bombay Air Cargo, LCS JAIGAON (INJIGB). Import: GRENADA, Saint George's, ST GEORGE, GEORGR TOWN.

Why does Grenada import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $685.4K corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply Grenada?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

What is the average shipment value for India to Grenada pharmaceutical trade?

$244 per consignment across 2,804 shipments.

How many Indian pharmaceutical companies export to Grenada?

37 Indian companies. Largest: MEDIGEN PHARMA with $278.3K.

How can I find verified Indian pharmaceutical suppliers for Grenada?

TransData Nexus covers 37 active exporters with shipment history and trade values at transdatanexus.com.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to Grenada identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 2,804 verified shipments from 37 Indian exporters to 45 Grenada buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

37 Exporters

45 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

India to Grenada Pharmaceutical Export